We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

8316:TSESumitomo Mitsui Financial Group, Inc. Analysis

Data as of 2026-03-09 - not real-time

¥5,210.00

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Sumitomo Mitsui Financial Group (8316.T) is trading at ¥5,210, comfortably above its 200‑day SMA (¥4,402) but below the 20‑day (¥5,787) and 50‑day (¥5,530) averages, indicating a short‑term pull‑back within a longer‑term bullish framework. The RSI sits at 40, suggesting modest oversold pressure, while the MACD remains bearish, hinting at near‑term downside risk. Despite a recent 18% QoQ dip in net income, revenue is expanding at a robust 21.8% annualised rate and the stock enjoys a PE of 13.9 versus the industry average of 17.4, positioning it as relatively cheap. The dividend yield of 2.9% with a 37% payout ratio appears sustainable, and the Fear‑Greed Index at “Extreme Greed” reflects strong market appetite.
The upside potential is quantified at roughly 12% with analyst fair‑value targets of ¥5,816 (mean) and ¥6,100 (median). Technical support at ¥5,028 and resistance at ¥6,284 frame the price corridor, while rising volume underpins the bullish trend. Morningstar’s revised efficiency outlook and a 19% uplift in fair‑value estimates add further confidence, making the stock an attractive blend of value and growth characteristics for medium‑ to long‑term investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • MACD bearish signal
  • Price near short‑term support
  • Increasing volume supporting trend

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervaluation relative to peers (PE 13.9 vs 17.4)
  • Revenue growth of 21.8% and solid dividend yield
  • Analyst fair‑value targets implying ~12% upside

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend and low payout ratio
  • Strong balance‑sheet with low leverage (beta 0.66)
  • Long‑term bullish trend and favorable earnings outlook

Key Metrics & Analysis

Financial Health

Revenue Growth21.80%
Profit Margin20.73%
P/E Ratio13.9
ROE4.93%
ROA0.24%
P/B Ratio1.3
Industry P/E17.4

Technical Analysis

TrendBullish
RSI40.3
Support¥5,028.00
Resistance¥6,284.00
MA 20¥5,787.15
MA 50¥5,530.28
MA 200¥4,401.99
MACDBearish
VolumeIncreasing
Fear & Greed Index75.89

Valuation

Target Price¥5,816.67
Upside/Downside11.64%
GradeUndervalued
TypeBlend
Dividend Yield2.90%

Risk Assessment

Beta0.67
Volatility48.53%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.